Matthew Paul Larson, Chief Risk Officer, on April 27, 2026, sold 56,002 shares in Slide Insurance Holdings (SLDE) for $1,107,098.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1886428/000119312526193259/xslF345X05/ownership.xml
Related Articles
Insider Trading
Kratos Defense & Security Solutions Insider Sold Shares Worth $431,451, According to a Recent SEC Filing
Steven S. Fendley, President, US Division, on April 27, 2026, sold 7,000 shares in Kratos Defense & Security Solutions (KTOS) for $431,451. Following the Form 4 filing with the SEC, Fendley has control over a total of 351,039 common shares of the company, with 351,039 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1069258/000169543426000006/xslF345X05/primary_doc.xml
$KTOS
Insider Trading
Revolution Medicines Insider Sold Shares Worth $413,129, According to a Recent SEC Filing
Anthony Mancini, Chief Global Commercialization Officer, on April 27, 2026, sold 3,120 shares in Revolution Medicines (RVMD) for $413,129. Following the Form 4 filing with the SEC, Mancini has control over a total of 54,400 common shares of the company, with 54,400 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1628171/000161071726000158/xslF345X05/form4.xml
$RVMD
Insider Trading
Gilead Sciences Insider Sold Shares Worth $1,291,608, According to a Recent SEC Filing
Daniel Patrick O'Day, Director, Chairman & CEO, on April 28, 2026, sold 10,000 shares in Gilead Sciences (GILD) for $1,291,608. Following the Form 4 filing with the SEC, O'Day has control over a total of 632,567 common shares of the company, with 632,567 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/882095/000163864326000020/xslF345X05/wk-form4_1777499620.xml
$GILD